(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-30 View latest technical analysis
10 day averaged volume of Array Biopharma is 4676203
Date | Daily Closing Price | Open | High | Low | Volume |
30 Fri Aug 2024 | 6.71 | 6.90 | 6.90 | 6.62 | 0.904 times |
30 Fri Aug 2024 | 6.71 | 6.90 | 6.90 | 6.62 | 0.904 times |
29 Thu Aug 2024 | 6.85 | 6.63 | 6.89 | 6.45 | 0.84 times |
28 Wed Aug 2024 | 6.52 | 6.55 | 6.59 | 6.25 | 0.832 times |
27 Tue Aug 2024 | 6.59 | 6.78 | 6.86 | 6.55 | 1.289 times |
26 Mon Aug 2024 | 6.89 | 7.06 | 7.45 | 6.88 | 1.365 times |
23 Fri Aug 2024 | 6.92 | 6.63 | 6.96 | 6.58 | 0.997 times |
22 Thu Aug 2024 | 6.56 | 6.71 | 6.74 | 6.49 | 0.881 times |
21 Wed Aug 2024 | 6.74 | 6.35 | 6.76 | 6.31 | 0.954 times |
20 Tue Aug 2024 | 6.37 | 6.72 | 6.85 | 6.35 | 1.318 times |
My analysis of stock is bearish for shortterm, and stock might move down till 6.2 or till 5.3. Use a stoploss of 7.04 and if the stock hits stoploss, then it can shoot up till 7.84
Share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Target | 6.25 |
Downside Target | 6.62 |
Upside Target | 6.76 |
Upside Target | 6.90 |
Upside Target | 7.18 |
Upside Target | 7.45 |
Upside Target | 9.34 |
Upside Target | 10.05 |
Upside Target | 10.60 |
Upside Target | 10.82 |
Upside Target | 12.06 |
Upside Target | 14.45 |
Upside Target | 14.85 |
Upside Target | 15.12 |
Intraday share price targets for Array Biopharma (ARRY)
Target Type | Value |
Downside Intraday Target | 6.59 |
Downside Intraday Target | 6.46 |
Upside Intraday Target | 6.87 |
Upside Intraday Target | 7.02 |
Upside Intraday Target | 6.74 |
Weekly technical analysis of Array Biopharma (ARRY)
Date | Weekly Closing Price | Open | High | Low | Volume |
30 Fri Aug 2024 | 6.71 | 6.90 | 6.90 | 6.62 | 0.173 times |
30 Fri Aug 2024 | 6.71 | 7.06 | 7.45 | 6.25 | 1.097 times |
23 Fri Aug 2024 | 6.92 | 6.58 | 6.96 | 6.31 | 0.543 times |
16 Fri Aug 2024 | 6.55 | 7.11 | 7.18 | 6.43 | 0.762 times |
09 Fri Aug 2024 | 7.10 | 9.01 | 9.34 | 6.76 | 2.238 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
Date | Monthly Closing Price | Open | High | Low | Volume |
30 Fri Aug 2024 | 6.71 | 10.50 | 10.79 | 6.25 | 1.404 times |
31 Wed Jul 2024 | 10.52 | 10.43 | 12.06 | 9.34 | 1.233 times |
28 Fri Jun 2024 | 10.26 | 14.12 | 14.45 | 10.05 | 0.666 times |
31 Fri May 2024 | 14.18 | 12.38 | 14.85 | 10.60 | 1.222 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.68 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Array Biopharma in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Array Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.68 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.